Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2021

View Archived Issues

Cosegregation powerfully classifies BRCA 1/2 variants

A separable microneedle patch improves delivery and storage of COVID-19 DNA nanovaccines

A large-scale analysis of loss of imprinting in naive and primed human pluripotent stem cells

Hybrid stem cell spheroids may advance stem cell-based therapies for CNS diseases and disorders

Researchers develop a murine model of retinal disease

NR5A2 as pharmacological target for nervous system malignancies

Purdue Research Foundation patents PD-1/PD-L1 interaction inhibitors

North China Pharmaceutical Group Semisyntech divulges GPX4 inhibitors

Zoetis Services identifies IL-1beta, IL-6 and TNF-alpha production inhibitors

Researchers synthesize new CDK inhibitors

Verge Analytics discovers new PIKfyve inhibitors

Study of APOE3 gene variant points to APOE aggregation as a target for treating dementia

VRDN-002 demonstrates promising PK profile in nonhuman primates

THRB agonist reduces aggressive phenotype in anaplastic thyroid cancer

Thymosin beta4 reverses cognitive impairment in mouse model of AD

RAC1 predicts dabrafenib resistance in papillary thyroid cancer

Amgen and Neumora collaborate in neuropsychiatric and neurodegenerative diseases

Chronic myeloid leukemia therapy may be enhanced by ULK1 inhibition

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....